Australia - English - Department of Health (Therapeutic Goods Administration)

i-care pharma distributors pty ltd - ocriplasmin, quantity: 1.25 mg/ml - injection, solution - excipient ingredients: mannitol; citric acid monohydrate; sodium chloride; sodium hydroxide; hydrochloric acid; water for injections - jetrea rtu is indicated in adults for the treatment of vitreomacular traction (vmt), including when associated with macular hole of diameter less than or equal to 400 microns.

Israel - English - Ministry of Health

bayer israel ltd - aflibercept - solution for intravitreal injection - aflibercept 40 mg/ml - aflibercept - eylea is indicated for adults for the treatment of • neovascular (wet) age-related macular degeneration (amd)• visual impairment due to macular oedema secondary to retinal vein occlusion (branch crvo or central rvo)• visual impairment due to diabetic macular oedema (dme)• visual impairment due to myopic choroidal neovascularisation (myopic cnv).

European Union - English - EMA (European Medicines Agency)

roche registration gmbh - faricimab - wet macular degeneration; macular edema; diabetes complications - ophthalmologicals - vabysmo is indicated for the treatment of adult patients with:neovascular (wet) age-related macular degeneration (namd),visual impairment due to diabetic macular oedema (dme).

European Union - English - EMA (European Medicines Agency)

novartis europharm limited  - brolucizumab - wet macular degeneration - ophthalmologicals - beovu is indicated in adults for the treatment of neovascular (wet) age-related macular degeneration (amd).

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - brolucizumab, quantity: 120 mg/ml - injection, solution - excipient ingredients: sodium citrate; sucrose; polysorbate 80; water for injections - beovu is indicated for the treatment of: - neovascular (wet) age-related macular degeneration (amd). - diabetic macular oedema (dme)

United States - English - NLM (National Library of Medicine)

newton laboratories, inc. - micrurus corallinus venom (unii: v0s6h36980) (micrurus corallinus venom - unii:v0s6h36980), aconitum napellus (unii: u0nq8555jd) (aconitum napellus - unii:u0nq8555jd), gold (unii: 79y1949pyo) (gold - unii:79y1949pyo), barium carbonate (unii: 6p669d8hq8) (barium cation - unii:v645272hln), atropa belladonna (unii: wqz3g9pf0h) (atropa belladonna - unii:wqz3g9pf0h), crotalus horridus horridus venom (unii: yha2xlj956) (crotalus horridus horridus venom - unii:yha2xlj956), gelsemium sempervirens root (unii: - micrurus corallinus venom 30 [hp_x] in 1 g - macular degeneration  formulated for symptoms of atrophic and neovascular forms of macular degeneration as well as symptoms associated with the macula and retina. formulated for symptoms of atrophic and neovascular forms of macular degeneration as well as symptoms associated with the macula and retina.

United States - English - NLM (National Library of Medicine)

newton laboratories, inc. - micrurus corallinus venom (unii: v0s6h36980) (micrurus corallinus venom - unii:v0s6h36980), aconitum napellus (unii: u0nq8555jd) (aconitum napellus - unii:u0nq8555jd), gold (unii: 79y1949pyo) (gold - unii:79y1949pyo), barium carbonate (unii: 6p669d8hq8) (barium cation - unii:v645272hln), atropa belladonna (unii: wqz3g9pf0h) (atropa belladonna - unii:wqz3g9pf0h), crotalus horridus horridus venom (unii: yha2xlj956) (crotalus horridus horridus venom - unii:yha2xlj956), gelsemium sempervirens root (unii: - micrurus corallinus venom 30 [hp_x] in 1 ml - macular degeneration  formulated for symptoms of atrophic and neovascular forms of macular degeneration as well as symptoms associated with the macula and retina. formulated for symptoms of atrophic and neovascular forms of macular degeneration as well as symptoms associated with the macula and retina.

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

wakamoto pharmaceutical co., ltd - triamcinolone acetonide - injection

Ireland - English - HPRA (Health Products Regulatory Authority)

g & a licensing limited - ketorolac trometamol - eye drops solution - 0.5 per cent

Ireland - English - HPRA (Health Products Regulatory Authority)

ltt pharma limited - ketorolac trometamol - eye drops solution - 0.5 %w/v